Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,596 | -21,828 | -98,792 | -73,627 | -51,625 |
| Accounts receivable | N/A | N/A | 512 | 512 | 512 |
| Accounts payable and accrued liabilities | 669 | 1,683 | -1,756 | -2,405 | -408 |
| Other Working Capital | -2,021 | 600 | 3,080 | -2,346 | -693 |
| Other Operating Activity | 14,649 | 6,508 | 45,296 | 36,456 | 22,435 |
| Operating Cash Flow | $-26,300 | $-13,037 | $-51,659 | $-41,410 | $-29,778 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 24,073 | 10,059 | 50,453 | 42,712 | 38,852 |
| Investing Cash Flow | $24,073 | $10,059 | $50,453 | $42,712 | $38,852 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 247 | 247 | N/A | N/A | N/A |
| Other Financing Activity | -25 | -25 | -99 | 0 | 0 |
| Financing Cash Flow | $222 | $222 | $-99 | $0 | $N/A |
| Beginning Cash Position | 4,092 | 4,092 | 5,396 | 5,396 | 5,396 |
| End Cash Position | 2,086 | 1,335 | 4,092 | 6,699 | 14,469 |
| Net Cash Flow | $-2,005 | $-2,757 | $-1,304 | $1,303 | $9,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,300 | -13,037 | -51,659 | -41,410 | -29,778 |
| Free Cash Flow | -26,300 | -13,037 | -51,659 | -41,410 | -29,778 |